News

The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.
Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?
Rapidly mutating DNA regions were mapped using a multi-generational family and advanced sequencing tools. Understanding how ...
Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million ...
KMAP projects DNA sequences—known as k-mers—into two-dimensional space, making it easier to identify and interpret biologically significant DNA sequence patterns, also called DNA motifs (fig ...
Researchers work in a mobile Fire-Eye laboratory in Beijing in June 2020. The labs can identify coronavirus infections, as well as decipher and analyze human DNA. (Fu Tian/China News Service/Getty ...